209 related articles for article (PubMed ID: 33344901)
1. Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
Goncalves T; Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Collopy LC; Strauss SJ; Mittnacht S; Tomita K
ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1253-1264. PubMed ID: 33344901
[TBL] [Abstract][Full Text] [Related]
2. Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition.
Deeg KI; Chung I; Bauer C; Rippe K
Front Oncol; 2016; 6():186. PubMed ID: 27602331
[TBL] [Abstract][Full Text] [Related]
3. Alternative Lengthening of Telomeres in Pediatric High-Grade Glioma and Therapeutic Implications.
Umaru B; Sengupta S; Senthil Kumar S; Drissi R
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370681
[TBL] [Abstract][Full Text] [Related]
4. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
5. SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
Mangosh TL; Grabowska MM; Taylor DJ
Prostate; 2021 Nov; 81(15):1235-1251. PubMed ID: 34492133
[TBL] [Abstract][Full Text] [Related]
6. Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.
Hou K; Yu Y; Li D; Zhang Y; Zhang K; Tong J; Yang K; Jia S
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565323
[TBL] [Abstract][Full Text] [Related]
7. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Flynn RL; Cox KE; Jeitany M; Wakimoto H; Bryll AR; Ganem NJ; Bersani F; Pineda JR; Suvà ML; Benes CH; Haber DA; Boussin FD; Zou L
Science; 2015 Jan; 347(6219):273-7. PubMed ID: 25593184
[TBL] [Abstract][Full Text] [Related]
8. Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.
Abid HZ; McCaffrey J; Raseley K; Young E; Lassahn K; Varapula D; Riethman H; Xiao M
BMC Genomics; 2020 Jul; 21(1):485. PubMed ID: 32669102
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of telomere maintenance mechanisms.
Hakobyan M; Binder H; Arakelyan A
J Biol Chem; 2024 May; 300(6):107392. PubMed ID: 38763334
[TBL] [Abstract][Full Text] [Related]
10. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
11. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
12. The role of recombination in telomere length maintenance.
Royle NJ; Méndez-Bermúdez A; Gravani A; Novo C; Foxon J; Williams J; Cotton V; Hidalgo A
Biochem Soc Trans; 2009 Jun; 37(Pt 3):589-95. PubMed ID: 19442255
[TBL] [Abstract][Full Text] [Related]
13. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
14. ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
Koneru B; Farooqi A; Nguyen TH; Chen WH; Hindle A; Eslinger C; Makena MR; Burrow TA; Wilson J; Smith A; Pilla Reddy V; Cadogan E; Durant ST; Reynolds CP
Sci Transl Med; 2021 Aug; 13(607):. PubMed ID: 34408079
[TBL] [Abstract][Full Text] [Related]
15. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
16. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
17. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Amato R; Valenzuela M; Berardinelli F; Salvati E; Maresca C; Leone S; Antoccia A; Sgura A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183119
[TBL] [Abstract][Full Text] [Related]
18. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
